Arbutus Biopharma Corporation

Arbutus Biopharma Corporationverified

ABUS

Price:

$3.18

Market Cap:

$602.58M

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel covalently conjugated N-acetylgalactosamine (GalNAc) delivery technology; and AB-836, an oral capsid inhibitor that suppresses HBV DNA replication. The company's research and development programs include AB-161, an oral HBV RNA destabilizer to destab...[Read more]

Industry

Biotechnology

IPO Date

2007-07-26

Stock Exchange

NASDAQ

Ticker

ABUS

The Current Ratio as of December 2024 (TTM) for Arbutus Biopharma Corporation (ABUS) is 7.02

According to Arbutus Biopharma Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 7.02. This represents a change of 7.36% compared to the average of 6.54 of the last 4 quarters.

Arbutus Biopharma Corporation (ABUS) Historical Current Ratio (quarterly & annually)

How has ABUS Current Ratio performed in the past?

The mean historical Current Ratio of Arbutus Biopharma Corporation over the last ten years is 11.19. The current 7.02 Current Ratio has changed 6.17% with respect to the historical average. Over the past ten years (40 quarters), ABUS's Current Ratio was at its highest in in the March 2020 quarter at 21.91. The Current Ratio was at its lowest in in the December 2022 quarter at 4.60.

Quarterly (TTM)
Annual

Average

11.19

Median

12.25

Minimum

4.60

Maximum

17.38

Arbutus Biopharma Corporation (ABUS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Arbutus Biopharma Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 115.05%

Maximum Annual Current Ratio = 17.38

Minimum Annual Increase = -67.87%

Minimum Annual Current Ratio = 4.60

Quarterly (TTM)
Annual
YearCurrent RatioChange
20235.8727.64%
20224.60-67.87%
202114.326.97%
202013.3811.67%
201911.99-7.23%
201812.9218.82%
201710.87-13.07%
201612.51-28.04%
201517.38115.05%
20148.0843.90%

Arbutus Biopharma Corporation (ABUS) Average Current Ratio

How has ABUS Current Ratio performed in the past?

The current Current Ratio of Arbutus Biopharma Corporation (ABUS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.26

5-year avg

10.03

10-year avg

11.19

Arbutus Biopharma Corporation (ABUS) Current Ratio vs. Peers

How is ABUS’s Current Ratio compared to its peers?

Arbutus Biopharma Corporation’s Current Ratio is greater than VBI Vaccines Inc. (0.34), less than ADMA Biologics, Inc. (7.09), greater than Adaptimmune Therapeutics plc (3.85), greater than Affimed N.V. (1.93), greater than Corvus Pharmaceuticals, Inc. (0.92),

Build a custom stock screener for Arbutus Biopharma Corporation (ABUS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arbutus Biopharma Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arbutus Biopharma Corporation (ABUS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arbutus Biopharma Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Arbutus Biopharma Corporation's Current Ratio?

How is the Current Ratio calculated for Arbutus Biopharma Corporation (ABUS)?

What is the highest Current Ratio for Arbutus Biopharma Corporation (ABUS)?

What is the 3-year average Current Ratio for Arbutus Biopharma Corporation (ABUS)?

What is the 5-year average Current Ratio for Arbutus Biopharma Corporation (ABUS)?

How does the current Current Ratio for Arbutus Biopharma Corporation (ABUS) compare to its historical average?